Literature DB >> 9990653

Effect of propranolol and nifedipine on maximal electroshock-induced seizures in mice: individually and in combination.

S S Raju1, H N Gopalakrishna, N Venkatadri.   

Abstract

A comparative effect of propranolol and nifedipine administered individually and in combination at graded dose levels; and that of phenytoin at 30 mg kg-1 on maximal electroshock (MES)-induced seizure in mice was investigated. Propranolol in doses of 10 mg kg-1 and 20 mg kg-1, and nifedipine in doses of 8 mg kg-1 and 16 mg kg-1 significantly modified MES activity. Propranolol (40 mg kg-1), and a combination of propranolol (20 mg kg-1) and nifedipine (8 mg kg-1), produced antiMES activity, which was comparable to that of phenytoin (30 mg kg-1). In mice treated with propranolol and nifedipine combination, the tonic flexor and tonic extensor phase ratios (F/E ratio) were significantly higher than individual drug responses. Our findings suggest that a combination of propranolol and nifedipine has either synergistic or an additive effect in controlling MES-induced seizures in mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9990653     DOI: 10.1006/phrs.1998.0390

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  3 in total

1.  Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: Search for add on therapy.

Authors:  Awanish Mishra; Rajesh Kumar Goel
Journal:  Metab Brain Dis       Date:  2015-01-23       Impact factor: 3.584

2.  Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice.

Authors:  Kinga K Borowicz-Reutt; Monika Banach; Monika Rudkowska
Journal:  Pharmacol Rep       Date:  2019-12-20       Impact factor: 3.024

Review 3.  Effects of Antiarrhythmic Drugs on Antiepileptic Drug Action-A Critical Review of Experimental Findings.

Authors:  Kinga K Borowicz-Reutt
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.